PATENT CLAIM ANALYSIS

Application Number: 15934413
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["424", "139100"]

Abstract:
Provided herein is an isolated antibody or antigen-binding fragment that specifically binds tau, the antibody or fragment comprising a heavy chain variable (VH) region and a light chain variable (VL) region having amino acid sequences set forth herein. Also provided are methods of preventing or treating a tauopathy in a subject, comprising administering to a human in need of therapy for a tauopathy with one or more antibodies or fragments as described herein, wherein the antibodies or antigen-binding fragments are administered under conditions and in an amount effective to prevent or treat the tauopathy.

Claim (Index 69):
The method of  claim 65 , wherein the expression is 13.4 micrograms per mL of culture media.

Metadata:
- Claim Count in Document: 59.0
- Percentile: 90.0
- Lexical Diversity: 1.58462
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15257086', '15742087', '15742070', '15906773', '14654176']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7631558816678692
- 35 USC 102 Novelty (BERT): 0.5618348549591119
- Combined Prediction Score: 0.7430237789969936
- Mean Citation Score: 407.851572
- Max Citation Score: 586.6301
- Similarity Product: 277.7867382240832

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test